Azenta, Inc.: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on May 9, 2024 and accepted by EDGAR at May 9, 2024, 16:24 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $159.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-10-01 to 2024-03-31 | $313.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-01-01 to 2024-03-31 | $95.7m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2023-10-01 to 2024-03-31 | $188.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-01-01 to 2024-03-31 | $63.4m | us-gaap:GrossProfit |
| Gross profit | 6 months2023-10-01 to 2024-03-31 | $124.9m | us-gaap:GrossProfit |
| Research and development | 3 months2024-01-01 to 2024-03-31 | $8.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2023-10-01 to 2024-03-31 | $17.2m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2024-01-01 to 2024-03-31 | $78.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-10-01 to 2024-03-31 | $156.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-01-01 to 2024-03-31 | −$147.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-10-01 to 2024-03-31 | −$173.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-01-01 to 2024-03-31 | −$260.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-10-01 to 2024-03-31 | −$450.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-01-01 to 2024-03-31 | −$136.9m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-10-01 to 2024-03-31 | −$152.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | −$2.47 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-10-01 to 2024-03-31 | −$2.72 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | −$2.47 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-10-01 to 2024-03-31 | −$2.72 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 55,440,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-10-01 to 2024-03-31 | 56,078,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-10-01 to 2024-03-31 | $34.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-10-01 to 2024-03-31 | $18.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2023-10-01 to 2024-03-31 | $186.8m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-03-31 | $353.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-31 | $1.19bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $2.56bn | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $203.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-31 | $340.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-03-31 | $2.22bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001558370-24-007628. Last ingested by Listed: Oct 30, 2026, 08:03 ET. Listed shows no prices and gives no investment advice.